Asbun demonstrated in results from the KATHERINE trial

Added on March 29, 2025

Address: 6-9 The Square, Stockley Park, Uxbridge, Middlesex UB11 1FW

Business Email: 2ntakh934o@illubd.com

Website: https://www.twosapp.com/67e6ff81802d3e834a5bd902

Abnormal results of investigations (e.g., laboratory studies of blood camples) were the most common adverse event, followed by cardiac disorders and nervous system disorders. Of patients treated with T-DM1, 9 experienced abnormal results of investigations, 5 experienced cardiac disorders, and 4 experienced nervous system disorders. Five cases each of abnormal results of investigations and cardiac disorders were present in the trastuzumab group, with no nervous system disorders occurring in this group.

Seven-year invasive-disease-free survival and seven-year overall survival rates in the immunohistochemistry (IHC) 2+ subgroup were 72.4% and 83.3% on T-DM1.

“These findings warrant evaluation of additional or alternative therapies to improve outcomes for these patients, including those who had initially presented with inoperable disease, those with positive axillary nodes after neoadjuvant therapy, and those with both IHC 2+ and ISH-amplified disease,” said researchers.

Asbun demonstrated in results from the KATHERINE trial

Managerial Accounting Assignment Help Excellence at Assignment Help AUS

Assignment Help

Best SOP Help

Leo Home Tutors & Academy in Rawalpindi

Ebook Writing Services

100% Success Strategy at BS Coaching Centre – Best Delhi Police Coaching in Nangloi

Take My Online Class

Best German Language Courses

Asbun demonstrated in results from the KATHERINE trial

Sign In

Register

Reset Password